Green Cross Corporation
Quick facts
| Founded | 1950 |
|---|
Marketed products
- Immunoglobulin G
- Shinbaro Capsule
- Step 1 · Diabetes
Step 1 is a recombinant human insulin used to lower blood glucose levels in people with diabetes. - Step 2 · Psychiatry
Step 2 is a medication used to treat opioid use disorder.
Phase 3 pipeline
- GC FLU inj. · Immunology / Infectious Disease
GC FLU is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains. - GC Flu(Trivalent) · Immunology / Infectious Disease
GC Flu(Trivalent) is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against three strains of influenza virus. - GC1107 · Oncology
GC1107 is a monoclonal antibody that blocks the PD-L1 checkpoint, enhancing anti-tumor immune responses by preventing PD-L1 from inhibiting T cell activation. - GC3102C · Diabetes
GC3102C is a small molecule that targets the SGLT2 receptor. - GC3107 · Virology / Immunology
GC3107 is a recombinant human albumin-fused interferon alpha (IFN-α) fusion protein that enhances antiviral and immunomodulatory activity. - GC3110A · Diabetes
GC3110A is a small molecule that targets the SGLT2 receptor. - GC3110A(Quadrivalent) · Immunology
GC3110A is a quadrivalent vaccine designed to stimulate immune responses against multiple disease targets. - GC3110A(Trivalent)
GC3110A is a trivalent vaccine designed to stimulate immune responses against multiple targets for therapeutic benefit. - GC3110A vaccine · Oncology
GC3110A is a therapeutic cancer vaccine designed to stimulate the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens. - GC3110B vaccine · Oncology
GC3110B is a therapeutic cancer vaccine designed to stimulate the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens. - GCFLU Pre-filled Syringe inj. · Immunology / Infectious Disease
GCFLU is a pre-filled syringe formulation of an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains. - GCFLU Quadrivalent Inj. vaccine · Immunology / Infectious Disease
GCFLU Quadrivalent is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against four strains of influenza virus. - GreenGene · Diabetes
GreenGene is a small molecule that targets the SGLT2 receptor. - GreenGene™ F · Diabetes
GreenGene F is a small molecule that targets the SGLT2 receptor. - Hantavax injection · Immunology / Infectious Disease
Hantavax is an inactivated vaccine that stimulates the immune system to produce antibodies against hantavirus, preventing infection with hantaviruses that cause hemorrhagic fever with renal syndrome (HFRS). - Human immunoglobulin intravenous · Immunology / Infectious Disease / Hematology
Human immunoglobulin intravenous (IVIG) provides passive immunity by delivering pooled antibodies from multiple human donors to neutralize pathogens and modulate immune responses. - Hunterase · Other
- Intradermal BCG SSI inj. · Oncology / Immunology
Intradermal BCG (Bacillus Calmette-Guérin) stimulates the immune system by activating innate and adaptive immunity to enhance anti-tumor or anti-infectious responses. - MG1109
MG1109 is a therapeutic agent in development by Green Cross Corporation currently in phase 3 clinical trials.
Phase 2 pipeline
- Boostrix® vaccine
- GC1102
- GC3111 vaccine
- GC3114
- GC5131 · Diabetes
GC5131 is a small molecule that targets the SGLT2 receptor. - GCFLU Quadrivalent
- I.V HBIG
- Suduvax · Other
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: